Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib
Crossref DOI link: https://doi.org/10.1007/s00277-016-2889-2
Published Online: 2016-12-08
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Berenson, Ariana
Vardanyan, Suzie
David, Michael
Wang, James
Harutyunyan, Nika Manik
Gottlieb, Jillian
Halleluyan, Ran
Spektor, Tanya M.
Udd, Kyle A.
Eshaghian, Shahrooz
Nassir, Youram
Eades, Benjamin
Swift, Regina
Berenson, James R.
License valid from 2016-12-08